drugset / Trial / NCT06319794

Study on the Safety and Efficacy of Bimiralisib Gel in Participants Suffering From Actinic Keratosis

NCT06319794

Phase 2 Completed 46 enrolled TORQUR
NaParallel-groupOpen-labelTreatment

Summary

The aim of the study is to evaluate efficacy and safety of bimiralisib gel treatment for treatment of actinic keratosis (AK) on the face and/or scalp and/or back of hands

Timeline

Start
2024-04-02
Primary completion
2025-06-24
Completion
2025-06-24

Drugs

EvaluationDrugModalityDoseRoute
Subject Bimiralisib Small molecule Topical

Indications